Exo vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Exo is a Redwood City medtech company developing handheld ultrasound devices using proprietary silicon-based PMUT technology; raised $220M+ in funding including a $100M Series C in 2022;
About
Exo is a medical technology company founded in 2015 and headquartered in Redwood City, California, focused on making high-performance ultrasound imaging accessible at the point of care. The company's hardware innovation centers on a proprietary silicon-based ultrasound transducer technology using Piezoelectric Micromachined Ultrasonic Transducers (PMUTs) — a semiconductor manufacturing approach to building ultrasound transducers rather than the traditional piezoelectric ceramic crystal approach used in conventional ultrasound probes. The PMUT-on-chip architecture enables Exo to produce ultrasound transducers that are significantly smaller, thinner, and lower-cost to manufacture at scale than conventional transducer technology, while potentially enabling future integration with computing electronics on the same chip.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.